ROCHE

Bondronat-bandrone

"Bondranat" contains Drug / Molecule called “Ibandronic acid”. Bondranat belongs to a class of medications known as bisphosphonate. Bondranat belongs to the bisphosphonate group of compounds which act specifically on bone. Their selective action on bone tissue is based on the high affinity of bisphosphonates for bone mineral.

“Bandrone” is the generic version of “Bondronat” and both contains same drug “Ibandronic Acid”

Details
Specification

Indication

Bondranat is used in prevention and treatment of osteoporosis, osteitisdeformans ("Paget's disease of bone"), bone metastasis (with or without hypercalcaemia), multiple myeloma, primary hyperparathyroidism, osteogenesisimperfecta, fibrous dysplasia, and other conditions that feature bone fragility.

Note

Precaution

Hypocalcaemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Bondronat therapy for metastatic bone disease.
Adequate intake of calcium and vitamin D is important in all patients. Patients should receive supplemental calcium and/or vitamin D if dietary intake is inadequate.
Bondronat is a prescription drug and should be used under proper medical guidance and advice.

Updated On Nov 02, 2019 by Admin

Strength

6 mg, 50 mg, 150 mg

Packing

1 X 7 Tablets (Strip) - 50 mg Vial - 6 mg

Storage

Tablets should be stored below 30 °C. Vial should be stored below 30 °C. After reconstitution, store at 2 C - 8 C.

Was this page helpful?

☆ ☆ ☆ ☆ ☆

Not Upto Date Insufficient Helpful

Any suggestions or inputs for Shubhampharma.

Bondronat-bandrone also available as

NATCO PHARMA LIMITED (INDIA)

Bandrone

"Bandrone" contains Drug / Molecule called “Ibandronic acid”. It belongs to a class of medications known as bisphosphonate. The action of ibandronate on bone tissue is based partly on its affinity for hydroxyapatite, which is part of the mineral matrix of bone. It functions by preventing the breakdown of bone by bone cells known as osteoclasts. This activity inhibits osteoclast activity and reduces bone resorption and turnover.